CONMED (NYSE:CNMD) Lowered to Hold Rating by Needham & Company LLC
Needham & Company LLC cut shares of CONMED (NYSE:CNMD – Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday morning, Marketbeat.com reports. They currently have $61.00 price objective on the stock. CNMD has been the topic of several other reports. Wells Fargo & Company lowered […]
Needham & Company LLC cut shares of CONMED (NYSE:CNMD – Free Report) from a buy rating to a hold rating in a research report sent to investors on Thursday morning, Marketbeat.com reports. They currently have $61.00 price objective on the stock. CNMD has been the topic of several other reports. Wells Fargo & Company lowered […]
